- World rank, all time
- #17,685 of 42,892
- Rank in China
- #1,861 of 3,536
- Research works
- 178 ▼ 52% vs 2013–17
- Citations
- 5k 28.3 per fractional work
- Top-10% rate
- 10.5% record average 16.5%
- Open access
- 44% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.4×. Every wedge is a field page.
- Immunology and Microbiology 6.4×
- Pharmacology, Toxicology and Pharmaceutics 4.2×
- Dentistry 4.1×
- Medicine 3.0×
- Mathematics 2.6×
- Decision Sciences 1.5×
- Health Professions 1.2×
- Veterinary 0.8×
- Biochemistry, Genetics and Molecular Biology 0.7×
- Neuroscience 0.6×
- Nursing 0.6×
- Economics, Econometrics and Finance 0.6×
- Computer Science 0.4×
- Engineering 0.4×
- Chemistry 0.3×
- Business, Management and Accounting 0.3×
- Social Sciences 0.3×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Psychology 0.1×
- Earth and Planetary Sciences 0.1×
- Materials Science 0.1×
- Physics and Astronomy 0.0×
Who are the top researchers at GlaxoSmithKline (China)?
Ranked on the composite score, Xichen Lin lead among researchers whose main affiliation is GlaxoSmithKline (China).
- 1 Xichen Lin China · #721,827 worldwide 56 citations · 16 works
Which keywords describe research at GlaxoSmithKline (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Management, Global Burden, Respiratory, Treatment, COPD and spirometry.
- Human Metapneumovirus
- Allergic Diseases
- Nanoparticles
- Asthma
- Immune Response
- Systemic Lupus Erythematosus
- Autoantibodies
- spirometry
- Treatment
- Global Burden
- Diagnosis
- Epidemiology
- Management
- Respiratory
- COPD
- Inflammation
- Antiphospholipid Syndrome
- Vaccine
- Pathogenesis
- Genetics
- Vaccine Development
- Eosinophils
- Respiratory Syncytial Virus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Epidemiology8▲ 6.6×27 topics
- Diagnosis4▲ 14×8 topics
- Management3▲ 14×6 topics
- Global Burden3▲ 18×4 topics
- Respiratory3▲ 95×2 topics
- Treatment3▲ 7.7×11 topics
- COPD2▲ 119×1 topic
- spirometry2▲ 119×1 topic
- Inflammation2▲ 3.2×10 topics
- Autoantibodies2▲ 28×4 topics
- Antiphospholipid Syndrome2▲ 123×1 topic
- Systemic Lupus Erythematosus2▲ 110×1 topic
- Vaccine2▲ 13×8 topics
- Immune Response1▲ 8.5×9 topics
- Pathogenesis1▲ 9.1×6 topics
- Asthma1▲ 40×2 topics
- Genetics1▲ 5.6×2 topics
- Nanoparticles1▲ 3.1×2 topics
- Vaccine Development1▲ 16×3 topics
- Allergic Diseases1▲ 65×1 topic
- Eosinophils1▲ 65×1 topic
- Human Metapneumovirus1▲ 79×1 topic
- Respiratory Syncytial Virus1▲ 79×1 topic
Which research topics does GlaxoSmithKline (China) publish most on?
By volume in 2022–2025: Chronic Obstructive Pulmonary Disease (COPD) Research, Systemic Lupus Erythematosus Research, Asthma and respiratory diseases and Respiratory viral infections research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
- 2 Systemic Lupus Erythematosus Research Rheumatology 2 works
- 3 Asthma and respiratory diseases Physiology 1 works
- 4 Respiratory viral infections research Epidemiology 1 works
- 5 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
- 6 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
- 7 Delphi Technique in Research Sociology and Political Science 1 works
- 8 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 9 Pediatric health and respiratory diseases Emergency Medical Services 1 works
- 10 Dental Erosion and Treatment Orthodontics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has GlaxoSmithKline (China)'s research output changed?
Output in 2018–2022 was 52% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.